Advertisement

Advertisement

AU:RAC Stock Latest News

Racura urges piggyback option holders to act as RC220 trial funding looms

Company AnnouncementsRacura urges piggyback option holders to act as RC220 trial funding looms

Racura Oncology Director Increases Stake Through $250,000 Option Exercise

PremiumCompany Announcements

Racura Oncology Director Increases Stake Through $250,000 Option Exercise

3d ago

Racura Oncology Seeks ASX Quotation for 1.4 Million New Shares

PremiumCompany Announcements

Racura Oncology Seeks ASX Quotation for 1.4 Million New Shares

3d ago

Racura Oncology Lists 1.43 Million New Shares on ASX

PremiumCompany Announcements

Racura Oncology Lists 1.43 Million New Shares on ASX

6d ago

Racura Oncology Seeks ASX Quotation for Additional Ordinary Shares

PremiumCompany Announcements

Racura Oncology Seeks ASX Quotation for Additional Ordinary Shares

10d ago

Racura Oncology Advances RC220 Clinical Program on Solid Cash Footing

PremiumCompany AnnouncementsRacura Oncology Advances RC220 Clinical Program on Solid Cash Footing

10d ago

Racura Wins NSW Grant to Advance BRCA-Targeted Cancer Therapy

Company Announcements

Racura Wins NSW Grant to Advance BRCA-Targeted Cancer Therapy

11d ago

Racura Oncology Options Lapse, Trimming Future Dilution Risk

Company Announcements

Racura Oncology Options Lapse, Trimming Future Dilution Risk

16d ago

Racura Oncology Seeks ASX Quotation for Over 1 Million New Shares

PremiumCompany Announcements

Racura Oncology Seeks ASX Quotation for Over 1 Million New Shares

17d ago

Racura Oncology Unveils MYC-Silencing Mechanism for Lead Cancer Drug at AACR 2026

PremiumCompany Announcements

Racura Oncology Unveils MYC-Silencing Mechanism for Lead Cancer Drug at AACR 2026

18d ago

Racura Oncology Seeks ASX Quotation for 325,199 New Shares

PremiumCompany Announcements

Racura Oncology Seeks ASX Quotation for 325,199 New Shares

24d ago

Racura Oncology targets Asian investors with Hong Kong and Singapore briefings

PremiumCompany Announcements

Racura Oncology targets Asian investors with Hong Kong and Singapore briefings

1M ago

Racura Oncology Seeks ASX Quotation for Newly Issued Shares

PremiumCompany AnnouncementsRacura Oncology Seeks ASX Quotation for Newly Issued Shares

1M ago

Race Oncology Director Boosts Shareholding via $250,000 Option Exercise

Company Announcements

Race Oncology Director Boosts Shareholding via $250,000 Option Exercise

1M ago

Racura Oncology Seeks ASX Quotation for 270,471 New Shares

Company Announcements

Racura Oncology Seeks ASX Quotation for 270,471 New Shares

1M ago

Racura Oncology Doses First Patient in Phase 1 Lung Cancer Trial of RC220 with Osimertinib

PremiumCompany Announcements

Racura Oncology Doses First Patient in Phase 1 Lung Cancer Trial of RC220 with Osimertinib

1M ago

Racura Oncology posts inaugural R&D symposium video to bolster visibility of late-stage cancer pipeline

PremiumCompany Announcements

Racura Oncology posts inaugural R&D symposium video to bolster visibility of late-stage cancer pipeline

1M ago

Racura Oncology Seeks ASX Quotation for 163,122 New Shares

PremiumCompany Announcements

Racura Oncology Seeks ASX Quotation for 163,122 New Shares

2M ago

Racura taps Purdue expertise to decode MYC-silencing mechanism of (E,E)-bisantrene

PremiumCompany Announcements

Racura taps Purdue expertise to decode MYC-silencing mechanism of (E,E)-bisantrene

2M ago

Racura showcases oncology pipeline at inaugural R&D investor symposium

PremiumCompany AnnouncementsRacura showcases oncology pipeline at inaugural R&D investor symposium

2M ago

Racura Oncology Seeks ASX Quotation for Additional Ordinary Shares

Company Announcements

Racura Oncology Seeks ASX Quotation for Additional Ordinary Shares

2M ago

Racura Completes First RC220 Dose Cohort in Global Solid Tumour Trial

Company Announcements

Racura Completes First RC220 Dose Cohort in Global Solid Tumour Trial

2M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >